首页> 外文期刊>Internet Journal of Orthopedic Surgery >Comparison between Hyalgan and Indomethacin in the treatment of osteoarthritis
【24h】

Comparison between Hyalgan and Indomethacin in the treatment of osteoarthritis

机译:Hyalgan与消炎痛治疗骨关节炎的比较

获取原文
           

摘要

Aim & purposes: Osteoarthritis (OA) is a disease with significant morbidity in patients. Knee joint is commonly involved in the OA. There is several treatment modalities, such as medical and surgical treatment. Many of patients interested to medical treatment and avoid surgical procedure. One of this treatment, treatment via indomethacin and hyaluronic preparation. This study was carried out in order to evaluate effect of hyalgan and indomethacin in the treatment of OA.Patients and methods: Patients with advanced grade of OA were included in this study. For this purpose, every patients with severe knee pain, limited range of motion, cryptation, joint stiffness, and difficulty in daily activity, were selected. Upright knee x-ray (AP, Lat) were obtained and radiologic changes were recorded. Before treatment, all cases were asked about pain, joint stiffness, knee cryptation, and other and were recorded. All patients received recommendation about activity modification and physiotherapy for quadriceps muscle. Then this patients were divided in two Hyalgan and Indomethacin groups. This study was conducted in the orthopedy clinic of Imam Khomeini Hospital, Ahwaz, Iran. Patients in Hyalgan groups , were received intra-articular injection 20mg weekly for 5 weeks. Patients in indomethacin group, were treated with dosage 25mg three times daily. All patients were evaluated post treatment.Results: in this study 39 patients (60 joints, 32 right and 28 left) underwent hyalgan and 27 patients( 50 joints, 25 right and 25 left) treated by indomethacin. From Hyalgan group 54 knee joint had grade IV and 6 have grade III radiology of OA. In the indomethacin group, 43 knee joints had grade IV and 7 joints had grade III. There is significant difference between two group for post treatment score(HA: 38.45?57.77 vs Indomethacin:32.16?67.29, P=0.00007). In the patients treated with HA, 56.67%, and 28.33% had excellent and good prognosis respectively. In indomethacin group 24.00%, and 34.00% had excellent and good prognosis respectively. Patients treated with HA had better outcome than patients treated with indomethacin( P-value=0.001475). In HA group, satisfaction about treatment was significantly higher than indomethacin group(P-value=0.003045). Pain in resting, morning stiffness, limitation in range of motion, and crypation was significantly lower in patients treated with HA compared to another (P<0.05). Pain at activity was significantly lower in indomethacin group(p<.05)Conclusion: this study showed significant effect of HA compared to indomethacin in reducing morning stiffness, pain during resting, limitation in ROM. This study support early administration of HA for treatment of OA. Introduction and aim Osteoarthritis (OA) is a disease with significant morbidity in the patients due its clinical manifestation and limited range of motion.1 Knee joint is one of the joint which is commonly involved. In the Framingham study, OA prevalence was reported 6% in the adults aged >30yrs. About half of the people aged >65 had evidence of OA.2 In addition to age, sex can also incidence and prevalence of OA. In the aged<50, OA predominately seen in male. After that, incidence and prevalence of OA was higher in female.3 Many patients are interested to non surgical treatment. There are several non surgical treatment modalities for treatment of OA. These treatments include lifestyle modification, NSAIDs, intraarticular injection of corticosteroid, and intra-articular hyalgan.4 Hyalgan has less adverse effect than intra-articular injection of corticosteroid.5 Hyalgan is a poly saccharide chain which seen in connective tissue in high quantity and prevents chondral damage.6 In OA, concentration and molecular weight of hyaluronate was reduced as 33-50%.7 The aim of this study was to compare of indomethacin and hyaluronic acid preparation for treatment of OA. Patients and methods Patients with advanced grade of OA were included in this study. For this purpose, every pat
机译:目的与目的:骨关节炎(OA)是一种在患者中具有高发病率的疾病。膝关节通常参与OA。有几种治疗方式,例如医学和外科治疗。许多对医疗感兴趣并避免手术的患者。其中一种治疗方法是通过消炎痛和透明质酸制剂进行治疗。进行这项研究是为了评估透明质酸和消炎痛在OA中的治疗作用。患者和方法:本研究纳入了晚期OA患者。为此,选择了每例膝关节疼痛严重,活动范围有限,隐秘,关节僵硬和日常活动困难的患者。获得了直立的膝盖X射线(AP,Lat)并记录了放射学变化。在治疗之前,询问所有病例有关疼痛,关节僵硬,膝盖隐窝等的情况,并进行记录。所有患者均获得有关股四头肌肌肉活动改变和理疗的建议。然后将该患者分为透明质酸和消炎痛两个组。这项研究是在伊朗阿瓦士的​​伊玛目霍梅尼医院的整形外科诊所进行的。 Hyalgan组的患者每周接受关节内注射20mg,持续5周。吲哚美辛组的患者每日25次,剂量为25mg。结果:在这项研究中,对39例患者(60关节,右32和左28)进行了透明质酸治疗,对27例患者(50关节,右25和左25)进行了消炎痛治疗。来自Hyalgan组的54个膝关节的OA放射线为IV级,而6位则为III级放射。在消炎痛组中,IV级膝关节43个,III级关节7个。两组治疗后评分差异有统计学意义(HA:38.45?57.77 vs吲哚美辛:32.16?67.29,P = 0.00007)。在接受HA治疗的患者中,分别有56.67%和28.33%的患者预后良好。消炎痛组24.00%和34.00%的患者预后良好。用HA治疗的患者比用消炎痛治疗的患者有更好的预后(P值= 0.001475)。在HA组中,对治疗的满意度显着高于消炎痛组(P值= 0.003045)。与另一组相比,接受HA治疗的患者的休息疼痛,早晨僵硬,活动范围受限和惊厥疼痛明显降低(P <0.05)。消炎痛组的活动疼痛明显降低(p <.05)。结论:这项研究表明,与消炎痛相比,HA在降低晨僵,休息时疼痛,ROM受限方面具有显着效果。这项研究支持早期给予HA治疗OA。简介和目的骨关节炎(OA)由于其临床表现和活动范围有限而在患者中具有很高的发病率。1膝关节是最常见的关节之一。在Framingham研究中,据报道,> 30岁的成年人中OA患病率为6%。 65岁以上的人中大约有一半有OA的证据。2除年龄外,性别还可以导致OA的发生和流行。在50岁以下的人群中,男性占多数。之后,女性OA的发生率和患病率更高。3许多患者对非手术治疗感兴趣。有几种非手术治疗OA的方法。这些治疗方法包括改变生活方式,非甾体抗炎药,关节内注射皮质类固醇和关节内透明质酸。4透明质酸比关节内注射皮质类固醇的不良反应要少5。 6在OA中,透明质酸的浓度和分子量降低了33%至50%。7本研究的目的是比较消炎痛和透明质酸制剂对OA的治疗作用。患者和方法本研究纳入了晚期OA患者。为此,每一拍

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号